One Battle Should Be Enough

Lymphedema is the most common long-term complication of breast cancer treatment — and when caught early, one of the most preventable. Cacto Health is developing MyLymphCare, an at-home monitoring solution using bioimpedance spectroscopy.

Lymphedema is the most common long-term complication of breast cancer treatment — and when caught early, one of the most preventable. Cacto Health is developing MyLymphCare, an at-home monitoring solution using bioimpedance spectroscopy.

Understanding

The Problem

Statistic showing 20% of women treated for breast cancer develop lymphedema today, reduced to under 5% with early detection and home monitoring.

Want to

Learn More?

Find out about the lymphatic system, the symptoms and the different stages of lymphedema after breast cancer

The Lived Experience

A Patient's Perspective

"I wish there had been better opportunity to detect the lymphedema early, and that there had been more focus on information about how you can detect it yourself."
Anne Madsen Tabor
Lymphedema patient

Discover

The Solution

Discover MyLymphCare home monitoring and how we can decrease risk of lymphedema.

Backed by

Our Mission

Prevention by Early Detection

Affiliations

Get to know

The Team

Ida Grønborg

Chief Executive Officer PhD, Researcher

Mads Skak

Chief Technology Officer M.Sc. Industrial Design

Greta Butkus

Regulatory Affairs/Quality Assurance Specialist, Medical Doctor